Microbiological (including mycological) tests are used in dermatology as a way to accurately diagnose skin diseases. Microbiological tests analyze the type of microorganisms present on the skin and detect any changes in quantity and/or type that might be causing skin ailments. Mycological tests are specific to detecting fungal infections, which can often be mistaken as other skin diseases. Microbiological testing is performed in a laboratory environment with the use of different sample collection techniques such as swabbing, aspirate, or biopsy. Common laboratory tests that are used in dermatology are optical microscopy, culture tests, PCR, enzyme-linked immunosorbent assay (ELISA), and other biochemical tests. These tests allow for the specific identification of the microorganism, identification of the level or severity of infection, and determination of sensitivity to certain antibiotics. In a dermatological setting, microbial testing is used to diagnose and treat a wide range of skin diseases such as acne, dandruff, impetigo, parasites, and various fungal infections. Mycological testing is specifically used to test for fungal infections, such as tinea, candidiasis, and dermatophytosis. The dermatologist will examine the skin and take samples form the affected area to diagnose the infection accurately. The sample will then be analyzed and laboratory tests can be used to identify the type of fungus causing the infection. Treatment for fungal infections includes antifungal creams or oral medications, depending on the type and severity of the infection. Overall, microbiological (including mycological) tests are essential in dermatology to diagnose and treat skin diseases accurately. The tests allow for screens for bacterial and fungal infections and the identification of the specific type of microorganisms causing the infection. Treatment options can then be tailored to the patient depending on the type and severity of the infection, as well as the patient’s health.
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : The new physiopathology of cellulite
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : A twelve week clinical study testing efficacy and safety of a cosmetic cream with novel actives for uneven skin tone, hyperpigmentation & photoaging
Nalini Kaul, Princeton Consumer Research, Canada
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Bioregeneration in aesthetic and functional gynecology
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : The management of FPHL- How it different from male AGA
Rachita Dhurat, LTMMC & LTMG Hospital, India
Title : Tackling stubborn wound by advanced polysaccharides-based biopolymer delivery system
Madhu Gupta, Delhi Pharmaceutical Science and Research University, India